Johnson & Johnson Seeks to End Decade-Long Talc Litigation with $5.5 Billion Settlement

Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement

Johnson & Johnson has struck a substantial deal worth more than five billion dollars, aimed at settling numerous lawsuits that allege cancer linked to its talc products. Following an ineffective bankruptcy resolution attempt, this latest agreement will facilitate quicker claims disbursement while keeping the door open for others who develop cancer-related claims in the future.

Johnson & Johnson agrees to pay billions in cancer lawsuit settlement

Johnson & Johnson agreed to pay up to $5.5 billion to settle approximately 76,000 lawsuits alleging that its talc products caused ovarian cancer.

Can J&J finally put the talc litigation behind it?

After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson says it has reached a settlement, worth at least US$5.5 billion, that could finally help bring an end to litigation that has dogged the company for over a decade. What is the talc litigation about? Tens of thousands of people have sued J&J in federal and state courts, alleging that its talc-based baby powder and other …

J&J reaches $5.5bn deal to settle talc baby powder cancer claims

Pharmaceutical giant Johnson & Johnson (J&J) has agreed to a proposed $5.5 billion settlement aimed at resolving approximately 76,000 lawsuits alleging that its talc-based baby powder and other talc products caused ovarian cancer, marking one of the largest product liability settlements in the company’s history. The proposed agreement, announced on Monday, is designed to bring an end to more than a decade of costly legal battles. Under the terms…